+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bone Cancer"

Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • April 2024
  • 1800 Pages
  • Global
From
Interventional Oncology Devices Global Market Report 2024 - Product Thumbnail Image

Interventional Oncology Devices Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Bone cancer is a type of cancer that affects the cells of the bones. It is a rare form of cancer, accounting for less than 1% of all cancers. It can occur in any bone in the body, but is most commonly found in the long bones of the arms and legs. Symptoms of bone cancer include pain, swelling, and tenderness in the affected area. Treatment options for bone cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The bone cancer market is a subset of the larger oncology market. It is a rapidly growing market, driven by advances in technology and treatments. The market is expected to continue to grow in the coming years, as new treatments and technologies are developed. Companies in the bone cancer market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. These companies are involved in the development and marketing of treatments for bone cancer. Show Less Read more